Cargando…
Effects of Gushukang for postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
BACKGROUND: Postmenopausal osteoporosis (PMO) is one of the most common systemic bone diseases with a high risk of fracture. Traditional herbal formula Gushukang (GSK) has been used to treat PMO. However, there is no systematic review related to GSK for PMO. The object of this work is to evaluate th...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337472/ https://www.ncbi.nlm.nih.gov/pubmed/32629684 http://dx.doi.org/10.1097/MD.0000000000020908 |